Markers of acute kidney failure

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01)

Patent

CA 2720644

The present invention relates to the method of determining the risk of acute kidney injury comprising determining the amount of a marker selected from VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM or any combination thereof in a sample.

La présente invention porte sur le procédé de détermination du risque de lésion rénale aiguë comprenant la détermination de la quantité d'un marqueur choisi parmi VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM ou n'importe quelle combinaison de ceux-ci dans un échantillon.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Markers of acute kidney failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Markers of acute kidney failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Markers of acute kidney failure will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1771822

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.